Crossmark

Integrated single-cell and bulk RNA sequencing analysis identifies a neoadjuvant chemotherapy-related gene signature for predicting survival and therapy in breast cancer

Crossref DOI link: https://doi.org/10.1186/s12920-023-01727-0

Published Online: 2023-11-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Xiaojun

Feng, Ran

Guo, Junbin

Pan, Lihui

Yao, Yarong

Gao, Jinnan
Funding

Funding for this research was provided by:

Shanxi Province “136 Revitalization Medical Project Construction Funds”
License Information

Text and Data Mining valid from 2023-11-23

Version of Record valid from 2023-11-23
More Information

Article History

Received: 12 April 2023

Accepted: 5 November 2023

First Online: 23 November 2023

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below